Cancer Research

Getting Your DNA Sequenced: Should Regulators Crack Down On Genetic Testing Companies?

California and New York regulators have been in the news lately (such as here and here), with their attempts to crack down on the nascent direct-to-consumer genetic testing industry. These states argue that companies like 23andMe, Navigenics, and several o ...

Article - Michael White - Jun 26 2008 - 9:46am

Does Pregnancy Confer Protection Against Bladder Cancer?

It seems pregnancy may confer some protection against bladder cancer- in mice. Female mice that had never become pregnant had approximately 15 times as much cancer in their bladders as their counterparts that had become pregnant, according to new findings ...

Article - News Staff - Jun 25 2008 - 11:49pm

European Approval For Roche's Pegasys Personalises Treatment For A Subgroup Of Hepatitis C Patients: Chance For Cure With Only F

BASEL, Switzerland, June 26 /PRNewswire/--- Roche Also Announces Start of NCORE Study to Determine Best Length of Treatment in Patients who do not Experience a Rapid Response Roche announced today that the European Commission has approved a shortened, 16- ...

Article - Anna Ohlden - Jun 26 2008 - 1:30am

How Pheromones Work Gets A New Theory

Pheromones are molecules that an organism releases to trigger a specific behavior in other members of its species. Insects make wide use of pheromones to attract mates, signal the location of food, warn of attackers and provide other signals. ...

Article - News Staff - Jun 26 2008 - 12:09pm

More Coffee, Less Liver Cancer

Liver cancer is the third most common global cause of cancer death and a new study may be good news for drinkers and growers. The large, prospective population-based study confirms an inverse relationship between coffee consumption and liver cancer risk. T ...

Article - News Staff - Jun 26 2008 - 11:27pm

ProStrakan Group Plc: Abstral (Rapinyl) Receives Positive CHMP Opinion For Breakthrough Cancer Pain

GALASHIELS, Scotland, June 27 /PRNewswire/-- ProStrakan Group plc (LSE: PSK), the international specialty pharmaceutical company, announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a ...

Article - Anna Ohlden - Jun 27 2008 - 3:30am

The "DNDi Project Of The Year": The Development Of Fexinidazole To Treat "Sleeping Sickness"

NERVIANO, Italy, June 27 /PRNewswire/--- Accelera Recognised as Key Partner in the Development of a New Therapy The development of fexinidazole for the treatment of African trypanosomiasis, commonly known as "sleeping sickness", by DNDi (Drugs f ...

Article - Anna Ohlden - Jun 27 2008 - 6:32am

Prostate Cancer: NICE Clarification Boosts NHS Treatment Options

LONDON, June 27 /PRNewswire/-- Physician experts at the British Association of Urological Surgeons' (BAUS) annual meeting this week heard how discussions with NICE have opened the way for patients with prostate cancer to have continued access to cryo ...

Article - Anna Ohlden - Jun 27 2008 - 10:32am

Cancer Cured? Granulocytes Treatment Worked 100 Percent In Mice Work But Will It Work In Humans?

Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice. The treatment will involve transfus ...

Article - News Staff - Jun 28 2008 - 3:08pm

No Place For Hypnotherapy And Acupuncture In An Evidence Based NHS Stop Smoking Service

LONDON, June 30 /PRNewswire/-- Smokers wishing to quit would be wasting their money if they use complementary therapies such as hypnotherapy or acupuncture- smoking cessation experts claim today (Monday, June 30). This and other issues around the most eff ...

Article - Anna Ohlden - Jun 30 2008 - 1:30am